WO2021067968A1 - Interventions sur le microbiome - Google Patents
Interventions sur le microbiome Download PDFInfo
- Publication number
- WO2021067968A1 WO2021067968A1 PCT/US2020/054316 US2020054316W WO2021067968A1 WO 2021067968 A1 WO2021067968 A1 WO 2021067968A1 US 2020054316 W US2020054316 W US 2020054316W WO 2021067968 A1 WO2021067968 A1 WO 2021067968A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- companion animal
- microbiome
- day
- bacterial
- Prior art date
Links
- 244000005700 microbiome Species 0.000 title claims abstract description 184
- 239000000203 mixture Substances 0.000 claims abstract description 222
- 241001465754 Metazoa Species 0.000 claims abstract description 165
- 230000036541 health Effects 0.000 claims abstract description 60
- 239000004615 ingredient Substances 0.000 claims abstract description 40
- 238000000034 method Methods 0.000 claims description 133
- 230000001580 bacterial effect Effects 0.000 claims description 105
- 235000013305 food Nutrition 0.000 claims description 52
- 241000894007 species Species 0.000 claims description 48
- 241000894006 Bacteria Species 0.000 claims description 41
- 230000002496 gastric effect Effects 0.000 claims description 40
- 210000003608 fece Anatomy 0.000 claims description 32
- 108090000623 proteins and genes Proteins 0.000 claims description 32
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 26
- 235000001014 amino acid Nutrition 0.000 claims description 22
- 150000001413 amino acids Chemical class 0.000 claims description 22
- 239000013589 supplement Substances 0.000 claims description 21
- 208000027244 Dysbiosis Diseases 0.000 claims description 20
- 241001112693 Lachnospiraceae Species 0.000 claims description 20
- 230000007140 dysbiosis Effects 0.000 claims description 20
- 241000588722 Escherichia Species 0.000 claims description 17
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 16
- 241000095588 Ruminococcaceae Species 0.000 claims description 15
- 241000605909 Fusobacterium Species 0.000 claims description 14
- 235000015097 nutrients Nutrition 0.000 claims description 14
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 claims description 14
- 206010012735 Diarrhoea Diseases 0.000 claims description 13
- 230000007423 decrease Effects 0.000 claims description 13
- 230000003247 decreasing effect Effects 0.000 claims description 13
- 241000193403 Clostridium Species 0.000 claims description 12
- 239000004475 Arginine Substances 0.000 claims description 11
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 11
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 11
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 11
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 11
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 11
- 235000003704 aspartic acid Nutrition 0.000 claims description 11
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 11
- 235000016068 Berberis vulgaris Nutrition 0.000 claims description 10
- 241000335053 Beta vulgaris Species 0.000 claims description 10
- 241001608234 Faecalibacterium Species 0.000 claims description 10
- 230000008859 change Effects 0.000 claims description 10
- 241001557932 Butyricicoccus Species 0.000 claims description 9
- 241000723343 Cichorium Species 0.000 claims description 9
- 235000007542 Cichorium intybus Nutrition 0.000 claims description 9
- 241000193163 Clostridioides difficile Species 0.000 claims description 9
- 241000305071 Enterobacterales Species 0.000 claims description 9
- 102000004169 proteins and genes Human genes 0.000 claims description 9
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 8
- 239000004471 Glycine Substances 0.000 claims description 8
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 8
- 210000004698 lymphocyte Anatomy 0.000 claims description 8
- 235000018102 proteins Nutrition 0.000 claims description 8
- BRMWTNUJHUMWMS-UHFFFAOYSA-N 3-Methylhistidine Natural products CN1C=NC(CC(N)C(O)=O)=C1 BRMWTNUJHUMWMS-UHFFFAOYSA-N 0.000 claims description 7
- 241000605956 Fusobacterium mortiferum Species 0.000 claims description 7
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims description 7
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 7
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 7
- JDHILDINMRGULE-LURJTMIESA-N N(pros)-methyl-L-histidine Chemical compound CN1C=NC=C1C[C@H](N)C(O)=O JDHILDINMRGULE-LURJTMIESA-N 0.000 claims description 7
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims description 7
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims description 7
- 108010077895 Sarcosine Proteins 0.000 claims description 7
- 241000607768 Shigella Species 0.000 claims description 7
- 241001425419 Turicibacter Species 0.000 claims description 7
- -1 camosine Chemical compound 0.000 claims description 7
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 7
- 229930182817 methionine Natural products 0.000 claims description 7
- 229960003104 ornithine Drugs 0.000 claims description 7
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 7
- 230000002829 reductive effect Effects 0.000 claims description 7
- 229940043230 sarcosine Drugs 0.000 claims description 7
- 241000193468 Clostridium perfringens Species 0.000 claims description 6
- 241001134638 Lachnospira Species 0.000 claims description 6
- 241000192142 Proteobacteria Species 0.000 claims description 6
- 241000605947 Roseburia Species 0.000 claims description 6
- 241001657520 Slackia Species 0.000 claims description 6
- 229940124277 aminobutyric acid Drugs 0.000 claims description 6
- 241000609971 Erysipelotrichaceae Species 0.000 claims description 5
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 5
- 241001464921 Phascolarctobacterium Species 0.000 claims description 5
- 241000605861 Prevotella Species 0.000 claims description 5
- 235000004279 alanine Nutrition 0.000 claims description 5
- 239000001913 cellulose Substances 0.000 claims description 5
- 229920002678 cellulose Polymers 0.000 claims description 5
- 235000013325 dietary fiber Nutrition 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 claims description 4
- 241000731710 Allobaculum Species 0.000 claims description 4
- 241000588921 Enterobacteriaceae Species 0.000 claims description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 4
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 4
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 4
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims description 4
- 244000269722 Thea sinensis Species 0.000 claims description 4
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims description 4
- 230000014509 gene expression Effects 0.000 claims description 4
- 229960002442 glucosamine Drugs 0.000 claims description 4
- 235000009569 green tea Nutrition 0.000 claims description 4
- 235000012680 lutein Nutrition 0.000 claims description 4
- 229960005375 lutein Drugs 0.000 claims description 4
- 239000001656 lutein Substances 0.000 claims description 4
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 4
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 4
- 235000012661 lycopene Nutrition 0.000 claims description 4
- 229960004999 lycopene Drugs 0.000 claims description 4
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims description 4
- 239000001751 lycopene Substances 0.000 claims description 4
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 4
- 235000013824 polyphenols Nutrition 0.000 claims description 4
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 4
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims description 4
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims description 4
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 4
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims description 4
- 238000001712 DNA sequencing Methods 0.000 claims description 3
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 claims description 3
- 238000003559 RNA-seq method Methods 0.000 claims description 3
- 241000209140 Triticum Species 0.000 claims description 3
- 235000021307 Triticum Nutrition 0.000 claims description 3
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 claims description 3
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 claims description 3
- 239000000090 biomarker Substances 0.000 claims description 3
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 claims description 3
- 229960002591 hydroxyproline Drugs 0.000 claims description 3
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 claims description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 2
- 230000000112 colonic effect Effects 0.000 claims description 2
- 241000606125 Bacteroides Species 0.000 claims 4
- 241000606126 Bacteroidaceae Species 0.000 claims 2
- 241000946390 Catenibacterium Species 0.000 claims 2
- 241001430149 Clostridiaceae Species 0.000 claims 2
- 241001183186 Fusobacteriaceae Species 0.000 claims 2
- 241000266824 Oscillospira Species 0.000 claims 2
- 240000003768 Solanum lycopersicum Species 0.000 claims 1
- 230000009429 distress Effects 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 abstract description 11
- 241000282326 Felis catus Species 0.000 abstract description 6
- 241000282324 Felis Species 0.000 abstract description 3
- 238000002405 diagnostic procedure Methods 0.000 abstract description 2
- 230000000968 intestinal effect Effects 0.000 description 98
- 241000282472 Canis lupus familiaris Species 0.000 description 81
- 235000005911 diet Nutrition 0.000 description 58
- 230000037213 diet Effects 0.000 description 47
- 239000000835 fiber Substances 0.000 description 37
- 230000037396 body weight Effects 0.000 description 33
- 235000021195 test diet Nutrition 0.000 description 25
- 239000006041 probiotic Substances 0.000 description 24
- 230000000529 probiotic effect Effects 0.000 description 24
- 235000018291 probiotics Nutrition 0.000 description 24
- 241000736262 Microbiota Species 0.000 description 23
- 230000000694 effects Effects 0.000 description 22
- 244000005709 gut microbiome Species 0.000 description 21
- 239000000047 product Substances 0.000 description 21
- 239000000523 sample Substances 0.000 description 19
- 238000011282 treatment Methods 0.000 description 18
- 235000013376 functional food Nutrition 0.000 description 14
- 230000007413 intestinal health Effects 0.000 description 14
- 238000004458 analytical method Methods 0.000 description 13
- 238000012360 testing method Methods 0.000 description 12
- 241001202853 Blautia Species 0.000 description 11
- 230000000378 dietary effect Effects 0.000 description 11
- 230000000813 microbial effect Effects 0.000 description 11
- 241001220441 Bacteroides plebeius Species 0.000 description 10
- 241000186394 Eubacterium Species 0.000 description 10
- 241000862469 Holdemania Species 0.000 description 10
- 238000011269 treatment regimen Methods 0.000 description 10
- 241000186000 Bifidobacterium Species 0.000 description 9
- 235000009697 arginine Nutrition 0.000 description 9
- 239000002417 nutraceutical Substances 0.000 description 9
- 235000021436 nutraceutical agent Nutrition 0.000 description 9
- 239000008194 pharmaceutical composition Substances 0.000 description 9
- 235000013406 prebiotics Nutrition 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 235000013930 proline Nutrition 0.000 description 9
- 238000011160 research Methods 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 235000021045 dietary change Nutrition 0.000 description 8
- 238000012423 maintenance Methods 0.000 description 8
- 230000004060 metabolic process Effects 0.000 description 8
- 238000012163 sequencing technique Methods 0.000 description 8
- 210000002966 serum Anatomy 0.000 description 8
- 241000194033 Enterococcus Species 0.000 description 7
- 241000186660 Lactobacillus Species 0.000 description 7
- 230000002550 fecal effect Effects 0.000 description 7
- 229940039696 lactobacillus Drugs 0.000 description 7
- 235000016709 nutrition Nutrition 0.000 description 7
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 6
- 241000605980 Faecalibacterium prausnitzii Species 0.000 description 6
- 235000021536 Sugar beet Nutrition 0.000 description 6
- 239000000654 additive Substances 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 244000052769 pathogen Species 0.000 description 6
- 238000010419 pet care Methods 0.000 description 6
- 241000282421 Canidae Species 0.000 description 5
- 241000124008 Mammalia Species 0.000 description 5
- 239000000061 acid fraction Substances 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 235000015872 dietary supplement Nutrition 0.000 description 5
- 230000002708 enhancing effect Effects 0.000 description 5
- 230000003993 interaction Effects 0.000 description 5
- 208000028774 intestinal disease Diseases 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000003753 real-time PCR Methods 0.000 description 5
- 150000004666 short chain fatty acids Chemical class 0.000 description 5
- 108020004465 16S ribosomal RNA Proteins 0.000 description 4
- 241001042642 Absiella Species 0.000 description 4
- 241001227086 Anaerostipes Species 0.000 description 4
- 241000282465 Canis Species 0.000 description 4
- 241001464956 Collinsella Species 0.000 description 4
- 241001143779 Dorea Species 0.000 description 4
- 241000089032 Erysipelatoclostridium Species 0.000 description 4
- 241000125969 Lachnoclostridium Species 0.000 description 4
- 241000043362 Megamonas Species 0.000 description 4
- 241000040577 Romboutsia Species 0.000 description 4
- 241000089063 Terrisporobacter Species 0.000 description 4
- 230000004888 barrier function Effects 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000001684 chronic effect Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 235000012041 food component Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000007366 host health Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 244000005706 microflora Species 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 210000003289 regulatory T cell Anatomy 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 241001013579 Anaerotruncus Species 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 3
- 108010087806 Carnosine Proteins 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 241001617393 Finegoldia Species 0.000 description 3
- 238000001135 Friedman test Methods 0.000 description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- 241000227653 Lycopersicon Species 0.000 description 3
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 3
- 241000093136 Sellimonas Species 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 3
- 229940044199 carnosine Drugs 0.000 description 3
- 230000024245 cell differentiation Effects 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 235000021196 dietary intervention Nutrition 0.000 description 3
- 230000001079 digestive effect Effects 0.000 description 3
- 238000001125 extrusion Methods 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 235000021323 fish oil Nutrition 0.000 description 3
- 235000013922 glutamic acid Nutrition 0.000 description 3
- 239000004220 glutamic acid Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 210000004347 intestinal mucosa Anatomy 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 238000002493 microarray Methods 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 230000004682 mucosal barrier function Effects 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 238000000513 principal component analysis Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000000306 recurrent effect Effects 0.000 description 3
- 235000002639 sodium chloride Nutrition 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- 241000239290 Araneae Species 0.000 description 2
- 241001148536 Bacteroides sp. Species 0.000 description 2
- 241001134770 Bifidobacterium animalis Species 0.000 description 2
- 241000186016 Bifidobacterium bifidum Species 0.000 description 2
- 241001608472 Bifidobacterium longum Species 0.000 description 2
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 description 2
- 241000772275 Blautia sp. Species 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 241000824799 Canis lupus dingo Species 0.000 description 2
- 206010009900 Colitis ulcerative Diseases 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 2
- 208000011231 Crohn disease Diseases 0.000 description 2
- 241000609468 Dorea sp. Species 0.000 description 2
- 238000001061 Dunnett's test Methods 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 208000004232 Enteritis Diseases 0.000 description 2
- 241000194031 Enterococcus faecium Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000192125 Firmicutes Species 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 238000012313 Kruskal-Wallis test Methods 0.000 description 2
- 240000001929 Lactobacillus brevis Species 0.000 description 2
- 241000186840 Lactobacillus fermentum Species 0.000 description 2
- 240000006024 Lactobacillus plantarum Species 0.000 description 2
- 241000186604 Lactobacillus reuteri Species 0.000 description 2
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 2
- 239000006057 Non-nutritive feed additive Substances 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 241000192001 Pediococcus Species 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 201000006704 Ulcerative Colitis Diseases 0.000 description 2
- 206010000059 abdominal discomfort Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 235000021120 animal protein Nutrition 0.000 description 2
- 229960003121 arginine Drugs 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 238000002869 basic local alignment search tool Methods 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000004422 calculation algorithm Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 2
- 229960005188 collagen Drugs 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 230000001332 colony forming effect Effects 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 210000004443 dendritic cell Anatomy 0.000 description 2
- 235000018823 dietary intake Nutrition 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- 208000010643 digestive system disease Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 208000037902 enteropathy Diseases 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000000556 factor analysis Methods 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000005417 food ingredient Substances 0.000 description 2
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 2
- 150000003271 galactooligosaccharides Chemical class 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000013632 homeostatic process Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000002551 irritable bowel syndrome Diseases 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 210000000207 lymphocyte subset Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 244000039328 opportunistic pathogen Species 0.000 description 2
- 235000019629 palatability Nutrition 0.000 description 2
- 230000037081 physical activity Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 235000021391 short chain fatty acids Nutrition 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- PXFBZOLANLWPMH-UHFFFAOYSA-N 16-Epiaffinine Natural products C1C(C2=CC=CC=C2N2)=C2C(=O)CC2C(=CC)CN(C)C1C2CO PXFBZOLANLWPMH-UHFFFAOYSA-N 0.000 description 1
- SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000521092 Alloprevotella Species 0.000 description 1
- 108091093088 Amplicon Proteins 0.000 description 1
- 229920000189 Arabinogalactan Polymers 0.000 description 1
- 239000001904 Arabinogalactan Substances 0.000 description 1
- 241001328122 Bacillus clausii Species 0.000 description 1
- 241001032451 Bacillus indicus Species 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 241000186018 Bifidobacterium adolescentis Species 0.000 description 1
- 241000901051 Bifidobacterium animalis subsp. animalis Species 0.000 description 1
- 241000185999 Bifidobacterium longum subsp. longum Species 0.000 description 1
- 241000186148 Bifidobacterium pseudolongum Species 0.000 description 1
- 241000131482 Bifidobacterium sp. Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 239000004344 EU approved packaging gas Substances 0.000 description 1
- 240000005595 Echinocereus dasyacanthus Species 0.000 description 1
- 235000008314 Echinocereus dasyacanthus Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 238000000729 Fisher's exact test Methods 0.000 description 1
- 241000662772 Flavonifractor Species 0.000 description 1
- 241001453172 Fusobacteria Species 0.000 description 1
- 206010017964 Gastrointestinal infection Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 241000442132 Lactarius lactarius Species 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 241000316282 Lactobacillus antri Species 0.000 description 1
- 241000905791 Lactobacillus apis Species 0.000 description 1
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 241001061980 Lactobacillus coleohominis Species 0.000 description 1
- 241000218492 Lactobacillus crispatus Species 0.000 description 1
- 241001134659 Lactobacillus curvatus Species 0.000 description 1
- 241000500356 Lactobacillus dextrinicus Species 0.000 description 1
- 241000186606 Lactobacillus gasseri Species 0.000 description 1
- 241001468157 Lactobacillus johnsonii Species 0.000 description 1
- 241000191683 Lactobacillus kisonensis Species 0.000 description 1
- 241000394636 Lactobacillus mucosae Species 0.000 description 1
- 241000186605 Lactobacillus paracasei Species 0.000 description 1
- 241001647418 Lactobacillus paralimentarius Species 0.000 description 1
- 241001448603 Lactobacillus perolens Species 0.000 description 1
- 241000186612 Lactobacillus sakei Species 0.000 description 1
- 241000186869 Lactobacillus salivarius Species 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 241000191998 Pediococcus acidilactici Species 0.000 description 1
- 241000177720 Pediococcus argentinicus Species 0.000 description 1
- 241001117188 Pediococcus claussenii Species 0.000 description 1
- 241000529920 Pediococcus parvulus Species 0.000 description 1
- 241000324734 Pediococcus stilesii Species 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 238000010793 Steam injection (oil industry) Methods 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 102000000591 Tight Junction Proteins Human genes 0.000 description 1
- 108010002321 Tight Junction Proteins Proteins 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 238000009557 abdominal ultrasonography Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 230000030741 antigen processing and presentation Effects 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000007234 antiinflammatory process Effects 0.000 description 1
- 230000011641 antimicrobial peptide production Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000019312 arabinogalactan Nutrition 0.000 description 1
- 235000004251 balanced diet Nutrition 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 208000024330 bloating Diseases 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 239000004464 cereal grain Substances 0.000 description 1
- 208000021735 chronic enteritis Diseases 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000012350 deep sequencing Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000003935 denaturing gradient gel electrophoresis Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000020785 dietary preference Nutrition 0.000 description 1
- 235000021004 dietary regimen Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 210000004921 distal colon Anatomy 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000002183 duodenal effect Effects 0.000 description 1
- 230000009982 effect on human Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 229940013317 fish oils Drugs 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 238000007672 fourth generation sequencing Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000007160 gastrointestinal dysfunction Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 150000002327 glycerophospholipids Chemical class 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 210000003692 ilium Anatomy 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 235000013980 iron oxide Nutrition 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 238000007477 logistic regression Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 230000003050 macronutrient Effects 0.000 description 1
- 235000021073 macronutrients Nutrition 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000010197 meta-analysis Methods 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 235000006286 nutrient intake Nutrition 0.000 description 1
- 235000021062 nutrient metabolism Nutrition 0.000 description 1
- 235000003170 nutritional factors Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 235000001954 papillon Nutrition 0.000 description 1
- 244000229285 papillon Species 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 238000010239 partial least squares discriminant analysis Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000007637 random forest analysis Methods 0.000 description 1
- 238000010845 search algorithm Methods 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001578 tight junction Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 235000020985 whole grains Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
- A23K10/37—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from waste material
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/111—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/179—Colouring agents, e.g. pigmenting or dyeing agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/717—Celluloses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/30—Oligoelements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Abstract
La présente invention concerne des compositions comprenant une gamme d'ingrédients appropriés pour une utilisation dans l'adaptation et/ou le traitement d'un animal de compagnie tel qu'un canidé (par exemple un chien) ou un félin (par exemple un chat) et leurs microbiomes, des outils de surveillance et des méthodes de diagnostic pour déterminer l'état de santé d'un animal de compagnie et son microbiome.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/766,103 US20220362324A1 (en) | 2019-10-04 | 2020-10-05 | Microbiome interventions |
EP20803681.4A EP4037493A1 (fr) | 2019-10-04 | 2020-10-05 | Interventions sur le microbiome |
CN202080070142.9A CN114786494A (zh) | 2019-10-04 | 2020-10-05 | 微生物组干预 |
EP24152595.5A EP4368730A2 (fr) | 2019-10-04 | 2020-10-05 | Interventions sur le microbiome |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB201914385A GB201914385D0 (en) | 2019-10-04 | 2019-10-04 | Microbiome Interventions |
GB1914385.8 | 2019-10-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2021067968A1 true WO2021067968A1 (fr) | 2021-04-08 |
Family
ID=68541381
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2020/054316 WO2021067968A1 (fr) | 2019-10-04 | 2020-10-05 | Interventions sur le microbiome |
Country Status (5)
Country | Link |
---|---|
US (1) | US20220362324A1 (fr) |
EP (2) | EP4368730A2 (fr) |
CN (1) | CN114786494A (fr) |
GB (1) | GB201914385D0 (fr) |
WO (1) | WO2021067968A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20210375430A1 (en) * | 2020-05-29 | 2021-12-02 | Kpn Innovations, Llc. | Methods, systems, and devices for generating a refreshment instruction set based on individual preferences |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050281910A1 (en) * | 1999-09-22 | 2005-12-22 | Eduardo Schiffrin | Method for increasing pet activity |
US8722112B2 (en) * | 2005-07-14 | 2014-05-13 | Hill's Pet Nutrition, Inc. | Method for prolonging the life of animals |
WO2017117091A1 (fr) * | 2015-12-30 | 2017-07-06 | Hill's Pet Nutrition, Inc. | Compositions alimentaires pour animal domestique |
WO2018006080A1 (fr) | 2016-07-01 | 2018-01-04 | Evolve Biosystems Inc. | Méthode pour faciliter la maturation du système immunitaire de mammifères |
US20180064140A1 (en) * | 2016-09-02 | 2018-03-08 | Nestec Sa | Compositions and methods for modulating gastrointestinal microflora in a canine |
US20200014292A1 (en) | 2017-02-17 | 2020-01-09 | General Electric Technology Gmbh | Improvements in or relating to gate drivers for gas tubes |
WO2020150712A1 (fr) | 2019-01-18 | 2020-07-23 | Mars, Incorporated | Outils de surveillance et méthodes de diagnostic |
-
2019
- 2019-10-04 GB GB201914385A patent/GB201914385D0/en not_active Ceased
-
2020
- 2020-10-05 CN CN202080070142.9A patent/CN114786494A/zh active Pending
- 2020-10-05 US US17/766,103 patent/US20220362324A1/en active Pending
- 2020-10-05 WO PCT/US2020/054316 patent/WO2021067968A1/fr unknown
- 2020-10-05 EP EP24152595.5A patent/EP4368730A2/fr active Pending
- 2020-10-05 EP EP20803681.4A patent/EP4037493A1/fr active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050281910A1 (en) * | 1999-09-22 | 2005-12-22 | Eduardo Schiffrin | Method for increasing pet activity |
US8722112B2 (en) * | 2005-07-14 | 2014-05-13 | Hill's Pet Nutrition, Inc. | Method for prolonging the life of animals |
WO2017117091A1 (fr) * | 2015-12-30 | 2017-07-06 | Hill's Pet Nutrition, Inc. | Compositions alimentaires pour animal domestique |
WO2018006080A1 (fr) | 2016-07-01 | 2018-01-04 | Evolve Biosystems Inc. | Méthode pour faciliter la maturation du système immunitaire de mammifères |
US20180064140A1 (en) * | 2016-09-02 | 2018-03-08 | Nestec Sa | Compositions and methods for modulating gastrointestinal microflora in a canine |
US20200014292A1 (en) | 2017-02-17 | 2020-01-09 | General Electric Technology Gmbh | Improvements in or relating to gate drivers for gas tubes |
WO2020150712A1 (fr) | 2019-01-18 | 2020-07-23 | Mars, Incorporated | Outils de surveillance et méthodes de diagnostic |
Non-Patent Citations (16)
Title |
---|
ANNA SALAS-MANI ET AL: "Fecal microbiota composition changes after a BW loss diet in Beagle dogs", JOURNAL OF ANIMAL SCIENCE, vol. 96, no. 8, 28 July 2018 (2018-07-28), US, pages 3102 - 3111, XP055698927, ISSN: 0021-8812, DOI: 10.1093/jas/sky193 * |
BIAGI G ET AL: "Influence of some potential prebiotics and fibre-rich foodstuffs on composition and activity of canine intestinal microbiota", ANIMAL FEED SCIENCE AND TECHNOLOGY, ELSEVIER, AMSTERDAM, NL, vol. 159, no. 1-2, 20 July 2010 (2010-07-20), pages 50 - 58, XP027118431, ISSN: 0377-8401, [retrieved on 20100714] * |
CARLO PINNA ET AL: "The Utilisation of Prebiotics and Synbiotics in Dogs", ITALIAN JOURNAL OF ANIMAL SCIENCE, vol. 13, no. 1, 1 January 2014 (2014-01-01), pages 3107, XP055764685, DOI: 10.4081/ijas.2014.3107 * |
DATABASE GNPD [online] MINTEL; 14 March 2019 (2019-03-14), ANONYMOUS: "Chicken + Vegetable Vitalized Nutrition Dog Food", XP055764797, Database accession no. 6403589 * |
DATABASE GNPD [online] MINTEL; 19 June 2019 (2019-06-19), ANONYMOUS: "Dog Food for Adult to Senior Maltese 10 Months and Up", XP055764765, Database accession no. 6643663 * |
DATABASE GNPD [online] MINTEL; 20 March 2019 (2019-03-20), ANONYMOUS: "Lamb Meal & Brown Rice Recipe Balanced Natural Nutrition Food for Adult Dogs", XP055764792, Database accession no. 6402839 * |
DATABASE GNPD [online] MINTEL; 20 September 2019 (2019-09-20), ANONYMOUS: "Chicken, Sweet Potato & Pumpkin Grain Free Adult Dog Food", XP055764788, Database accession no. 6880667 * |
DATABASE GNPD [online] MINTEL; 21 August 2019 (2019-08-21), ANONYMOUS: "Wishbone Chicken & Green Lentil Recipe Dog Food", XP055764790, Database accession no. 6795561 * |
DATABASE GNPD [online] MINTEL; 22 September 2017 (2017-09-22), ANONYMOUS: "Super Premium Food For Senior Dogs", XP055764762, Database accession no. 5123787 * |
DATABASE GNPD [online] MINTEL; 26 September 2019 (2019-09-26), ANONYMOUS: "Complete Adult Dog Food Rich in Chicken", XP055764808, Database accession no. 6898417 * |
DATABASE GNPD [online] MINTEL; 27 August 2019 (2019-08-27), ANONYMOUS: "Adult Dog Food", XP055764811, Database accession no. 6815593 * |
DATABASE GNPD [online] MINTEL; 7 May 2019 (2019-05-07), ANONYMOUS: "Fit & Firm 7+ Senior Dog Food", XP055764814, Database accession no. 6520579 * |
DATABASE GNPD [online] MINTEL; 9 July 2019 (2019-07-09), ANONYMOUS: "Chicken, Barley & Rice Light Pet Food for Senior Dogs", XP055764813, Database accession no. 6692371 * |
HART ET AL., PLOS ONE, vol. 10, no. 11, 24 November 2015 (2015-11-24), pages e0143334 |
JAN S. SUCHODOLSKI ET AL: "The Fecal Microbiome in Dogs with Acute Diarrhea and Idiopathic Inflammatory Bowel Disease", PLOS ONE, vol. 7, no. 12, 26 December 2012 (2012-12-26), pages e51907, XP055221020, DOI: 10.1371/journal.pone.0051907 * |
KRISTY N KUZMUK ET AL: "Nutrient Metabolism Diet and Age Affect Intestinal Morphology and Large Bowel Fermentative End-Product Concentrations in Senior and Young Adult Dogs 1,2", 4 May 2005 (2005-05-04), pages 1 - 6, XP055418537, Retrieved from the Internet <URL:http://jn.nutrition.org/content/135/8/1940.full.pdf> [retrieved on 20171024] * |
Also Published As
Publication number | Publication date |
---|---|
GB201914385D0 (en) | 2019-11-20 |
EP4037493A1 (fr) | 2022-08-10 |
CN114786494A (zh) | 2022-07-22 |
EP4368730A2 (fr) | 2024-05-15 |
US20220362324A1 (en) | 2022-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Deng et al. | Gut microbiota of humans, dogs and cats: current knowledge and future opportunities and challenges | |
Yu et al. | Improved extraction of PCR-quality community DNA from digesta and fecal samples | |
Lin et al. | Effects of a Saccharomyces cerevisiae fermentation product on fecal characteristics, nutrient digestibility, fecal fermentative end-products, fecal microbial populations, immune function, and diet palatability in adult dogs | |
Bresciani et al. | Effect of an extruded animal protein‐free diet on fecal microbiota of dogs with food‐responsive enteropathy | |
US20220117265A1 (en) | Methods and compositions for treating intestinal dysbiosis | |
Zhang et al. | The development of the gastrointestinal tract microbiota and intervention in neonatal ruminants | |
US20220119864A1 (en) | Canid microbiome monitoring tools and diagnostic methods | |
Mori et al. | Oral administration of multispecies microbial supplements to sows influences the composition of gut microbiota and fecal organic acids in their post-weaned piglets | |
Belhassen et al. | Effect of diet supplementation with live yeast Saccharomyces cerevisiae on growth performance, caecal ecosystem and health of growing rabbits | |
Qiao et al. | Effects of dietary poly-β-hydroxybutyrate supplementation on the growth, immune response and intestinal microbiota of soiny mullet (Liza haematocheila) | |
Zhang et al. | The effects of milk replacer allowance and weaning age on the performance, nutrients digestibility, and ruminal microbiota communities of lambs | |
JP2023093682A (ja) | Pmas方法を利用したパーソナライズ腸内環境改善物質スクリーニング方法 | |
Zhao et al. | Gut microbiome of Chinese forest musk deer examined across gender and age | |
Wu et al. | Assessing the intestinal bacterial community of farmed Nile tilapia (Oreochromis niloticus) by high-throughput absolute abundance quantification | |
Feng et al. | The effects of dietary Lactococcus spp. on growth performance, glucose absorption and metabolism of common carp, Cyprinus carpio L. | |
Guo et al. | The impacts of fermented feed on laying performance, egg quality, immune function, intestinal morphology and microbiota of laying hens in the late laying cycle | |
Wu et al. | Effects of multispecies probiotic on intestinal microbiota and mucosal barrier function of neonatal calves infected with e. Coli k99 | |
Hansen et al. | Impact of early inoculation of probiotics to suckling piglets on postweaning diarrhoea–a challenge study with Enterotoxigenic E. Coli F18 | |
US20220362324A1 (en) | Microbiome interventions | |
US20220378864A1 (en) | Microbiome interventions | |
Wen et al. | Thiamine modulates intestinal morphological structure and microbiota under subacute ruminal acidosis induced by a high-concentrate diet in Saanen goats | |
Yan et al. | Harnessing the strategy of metagenomics for exploring the intestinal microecology of sable (Martes zibellina), the national first-level protected animal | |
Zhang et al. | Metagenomic analysis for exploring the potential of Lactobacillus yoelii FYL1 to mitigate bacterial diarrhea and changes in the gut microbiota of juvenile yaks | |
Gois et al. | Effects of adding a prebiotic product based of beta-glucans, glucomannans, and mannan-oligosaccharides on performance and health of weanling pigs | |
CN113631724A (zh) | 用于确定犬科动物的微生物组的年龄状态的监测工具和诊断方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 20803681 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2020803681 Country of ref document: EP Effective date: 20220504 |